Coport L 10/5 mg Tablet is a fixed-dose combination medication manufactured by ACI Limited, designed to manage type 2 diabetes mellitus. It combines two active ingredients:
Empagliflozin (10 mg): An SGLT2 (sodium-glucose co-transporter 2) inhibitor that works by preventing glucose reabsorption in the kidneys, leading to increased glucose excretion through urine and thereby lowering blood sugar levels.
Linagliptin (5 mg): A DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances insulin release and decreases glucagon levels in the blood, which helps in controlling blood sugar levels